Promising results from psilocybin trial for treatment-resistant depression

Researchers have participated in the largest and most rigorous clinical trial to date of psilocybin (a psychoactive ingredient in magic mushrooms), pointing to the possibility that COMP360 psilocybin with psychological support could be a beneficial therapeutic strategy for people with treatment-resistant depression (TRD).

from Latest Science News -- ScienceDaily https://ift.tt/zU5XIq1